+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Vitamin D Testing Market 2019-2023 - Product Image

Global Vitamin D Testing Market 2019-2023

  • ID: 4804061
  • Report
  • July 2019
  • Region: Global
  • 132 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
Global Vitamin D Testing Market: About this market

Vitamin D is needed to maintain serum calcium and phosphate concentration to regularize the mineralization of bone and tooth. The vitamin D testing market analysis considers sales from both 25-hydroxyvitamin D testing and 1,25-dihydroxyvitamin D testing. This analysis also considers the sales of vitamin D testing in Asia, Europe, North America, and ROW. In 2018, the 25-hydroxyvitamin D testing segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of vitamin D deficiency disorders will play a significant role in the 25-hydroxyvitamin D testing segment to maintain its market position. Also, our global vitamin D testing market report also looks at factors such as growing awareness on the importance of vitamin D, growing number of vitamin D deficiency-related disorders, and increasing geriatric population. However, product recalls posing challenge to the manufacturers, lack of awareness and limited healthcare services in developing regions, and lack of standard regulatory testing guidelines may hamper the growth of the vitamin D testing industry over the forecast period.

Global Vitamin D Testing Market: Overview

Growing number of vitamin D deficiency-related disorders

Rickets, a disease in which bone tissue does not properly mineralize, leading to soft bones and skeletal deformities in children is caused due to vitamin D deficiency. The deficiency in an adult causes mineralization problem in the skeleton, causing osteomalacia. Also, deficiency of vitamin D is related to increased risk of acquiring diabetes, immune system diseases, and neuropsychiatric disorder. The increasing prevalence of vitamin D deficiency-related disorders due to growing life expectancy will lead to the expansion of the global vitamin D testing market at a CAGR of almost 5% during the forecast period.

An increasing number of infections and autoimmune diseases

Vitamin D plays a key role in managing the immune system, as vitamin D receptor is expressed in all immune cells that include B cells, T cells, and antigen-presenting cells. These immunological cells can synthesize active vitamin D metabolites, thereby helping vitamin D to modulate the innate and adaptive immune responses. Vitamin D deficiency is linked with increased autoimmunity and susceptibility to infectious diseases caused by organisms such as bacteria, virus, fungi, and parasites. The increasing number of infections and autoimmune diseases is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global vitamin D testing market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global vitamin D testing market is fairly concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin D testing companies, that include Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH.

Also, the vitamin D testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • 25-hydroxyvitamin D testing - Market size and forecast 2018-2023
  • 1,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Increasing number of infections and autoimmune diseases
  • Growing number of strategic developments by vendors
  • Innovative product offerings by vendors
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: About the Author


List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: -hydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Parameters for 25-hydroxyvitamin serum concentrations
Exhibit 22: -hydroxyvitamin D testing - Year-over-year growth 2019-2023 (%)
Exhibit 23: ,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: ,25-dihydroxyvitamin D testing - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global vitamin D testing market share by end-users 2018
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Recommended dietary allowance for vitamin D by age and gender
Exhibit 32: North America - Year-over-year growth 2019-2023 (%)
Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott Laboratories - Vendor overview
Exhibit 48: Abbott Laboratories - Business segments
Exhibit 49: Abbott Laboratories - Organizational developments
Exhibit 50: Abbott Laboratories - Geographic focus
Exhibit 51: Abbott Laboratories - Segment focus
Exhibit 52: Abbott Laboratories - Key offerings
Exhibit 53: bioMérieux SA - Vendor overview
Exhibit 54: bioMérieux SA - Business segments
Exhibit 55: bioMérieux SA - Organizational developments
Exhibit 56: bioMérieux SA - Geographic focus
Exhibit 57: bioMérieux SA - Key offerings
Exhibit 58: Danaher Corp. - Vendor overview
Exhibit 59: Danaher Corp. - Business segments
Exhibit 60: Danaher Corp. - Organizational developments
Exhibit 61: Danaher Corp. - Geographic focus
Exhibit 62: Danaher Corp. - Segment focus
Exhibit 63: Danaher Corp. - Key offerings
Exhibit 64: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 65: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 66: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 67: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 68: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 69: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 70: Siemens Healthcare GmbH - Vendor overview
Exhibit 71: Siemens Healthcare GmbH - Business segments
Exhibit 72: Siemens Healthcare GmbH - Organizational developments
Exhibit 73: Siemens Healthcare GmbH - Geographic focus
Exhibit 74: Siemens Healthcare GmbH - Segment focus
Exhibit 75: Siemens Healthcare GmbH - Key offerings
Exhibit 76: Validation techniques employed for market sizing
Exhibit 77: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
The following companies are recognised as the key players in the global vitamin D testing market: Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing number of infections and autoimmune diseases”

According to the report, one of the major drivers for this market is the growing number of vitamin D deficiency-related disorders.

Further, the report states that one of the major factors hindering the growth of this market is the product recalls posing challenge to the manufacturers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH.
Note: Product cover images may vary from those shown
Adroll
adroll